Mankind Pharma Q4 Results

  • BSE: 543904
  • NSE: MANKIND
  • ISIN: INE634S01028
  • Sector: -
BSE
2,62876.45 (3.00%)
Volume9.32 K
Updated: Mon 25 Nov, 2024 | 15:29:25
NSE
2,62573.40 (2.88%)
Volume6.94 L
Updated: Mon 25 Nov, 2024 | 15:29:59
Today: 2,559.05
2,660.00
52-Wk: 1,820.15
2,882.75

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Mankind Pharma Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 23QoQ Comp
    Total Revenue 2,441.102,606.96-%
    Selling/ General/ Admin Expenses Total 599.89568.35-%
    Depreciation/ Amortization 104.69109.73-%
    Other Operating Expenses Total 512.81604.51-%
    Total Operating Expense 1,954.682,110.18-%
    Operating Income 486.42496.78-%
    Net Income Before Taxes 571.58562.33-%
    Net Income 471.24453.76-%
    Diluted Normalized EPS 11.7411.31-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts